Our patented Sound Bites platform offers a convenient, unbiased way for oncologists to stay up-to-date.

Critical, on-demand information right at your fingertips when and where it is most convenient for you. Subscribe to receive 60 – 90 second video clips from thought leaders via text message.

Free to healthcare providers. No ads, no sponsorships, no bias.

Intended for USA healthcare providers only.

Browse Clinical Trial Updates

All
ASCO Updates
Breast Cancer
GI Cancers
GU Cancers
GYN Oncology
Hematological Malignancies
Lung Cancer
Skin Cancer
Dr. Charu Aggarwal discusses the efficacy of datopotamab deruxtecan in pretreated mNSCLC (Video 1/3)

Dr. Charu Aggarwal discusses the efficacy of datopotamab deruxtecan in pretreated mNSCLC (Video 1/3)

TROPION Lung Efficacy

Charu Aggarwal, MD
Lung Cancer
Dr. Eric Singhi reviews 5-year efficacy of cemiplimab + chemotherapy in aNSCLC (Video 1/3)

Dr. Eric Singhi reviews 5-year efficacy of cemiplimab + chemotherapy in aNSCLC (Video 1/3)

EMPOWER Squamous

Eric Singhi , MD
Lung Cancer
Dr. Joshua Zeidner reviews the data for revumenib in patients with NPM1-mutated AML (Video 3/3)

Dr. Joshua Zeidner reviews the data for revumenib in patients with NPM1-mutated AML (Video 3/3)

Revumenib NPM1m

Joshua Zeidner, MD
Hematological Malignancies
Dr. Hossein Borghaei describes the safety of nivo/ipi + chemo in patients with mNSCLC and the efficacy in patients who discontinue early. (Video 3/3)

Dr. Hossein Borghaei describes the safety of nivo/ipi + chemo in patients with mNSCLC and the efficacy in patients who discontinue early. (Video 3/3)

CM-9LA TRAEs

Hossein Borghaei, MD
Lung Cancer
Dr. Arvind Dasari gives an overview of ctDNA with a focus on why the data from Galaxy and Bespoke-CRC was pooled for surveillance (Video 1/3)

Dr. Arvind Dasari gives an overview of ctDNA with a focus on why the data from Galaxy and Bespoke-CRC was pooled for surveillance (Video 1/3)

CtDNA pooled data

Arvind Dasari, MD
GI Cancers
Dr. Melissa Johnson describes the safety of atezolizumab + lurbinectedin maintenance therapy in 1L ES-SCLC. (Video 3/3)

Dr. Melissa Johnson describes the safety of atezolizumab + lurbinectedin maintenance therapy in 1L ES-SCLC. (Video 3/3)

IMforte Safety

Melissa Johnson
Lung Cancer

Why subscribe?

  • Get one-minute, non-promotional, educational videos from distinguished thought leaders
  • Tailored to topics you select
    • Breast Cancer
    • Lung Cancer
    • Gastrointestinal Cancers
    • Genitourinary Cancers
    • Gynecologic Cancers
    • Hemotologic Malignancies
    • Conference updates and more
  • No spam. No ads. No apps to download.
  • Always free and you can opt-out anytime if you feel this isn’t for you.

Fill out the form above to subscribe!

Our patented Sound Bites platform offers a convenient, unbiased way for oncologists to stay up-to-date.

Critical, on-demand information right at your fingertips when and where it is most convenient for you. Subscribe to receive 60 – 90 second video clips from thought leaders via text message.

Intended for USA healthcare providers only.

If your institution is not listed, please select "Other"

By clicking Subscribe, I agree that I have read and understand IDEOlogy Health’s Privacy Policy and Terms and Conditions and further agree to receive information from IDEOlogy Health and its companies

ideology-health
Privacy Policy
Terms of Service

IDEOlogy Health Ranks No. 772 on the 2025 Inc. 5000 Fastest-Growing Private Companies in America

© 2025 IDEOlogy Health. All product names, logos, brands, trademarks and registered trademarks are property of their respective owners and their use(s) do not necessarily imply endorsement.